Naprod Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
- Paid Up Capital ₹ 3.02 Cr
- Company Age 34 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 56.10 Cr
- Satisfied Charges ₹ 9.24 Cr
- Revenue Growth 26.24%
- Profit Growth 14.60%
- Ebitda 15.62%
- Net Worth 11.32%
- Total Assets 13.07%
About Naprod Life Sciences
Naprod Life Sciences Private Limited (NLSPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 July 1990 and has a history of 34 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Neon Antibiotics Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 3.02 Cr.
The company currently has active open charges totaling ₹56.10 Cr. The company has closed loans amounting to ₹9.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mohan Jain and Manish Jain serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230MH1990PTC057496
- Company No.
057496
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jul 1990
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Naprod Life Sciences Private Limited offer?
Naprod Life Sciences Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Third Party Manufacturing, Anti Cancer Medicines, Oncology Drug, Content Writing Service, Research Development Services.
Who are the key members and board of directors at Naprod Life Sciences?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mohan Jain ![]() | Director | 02-Mar-1994 | Current |
Manish Jain ![]() | Director | 11-Sep-2018 | Current |
Financial Performance of Naprod Life Sciences.
Naprod Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 26.24% increase. The company also saw a substantial improvement in profitability, with a 14.6% increase in profit. The company's net worth Soared by an impressive increase of 11.32%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Naprod Life Sciences?
In 2023, Naprod Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹56.10 Cr
₹9.24 Cr
Charges Breakdown by Lending Institutions
- Others : 56.10 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
27 Jun 2022 | Others | ₹56.00 Cr | Open |
02 Jan 2020 | Others | ₹1.00 M | Open |
22 Feb 2007 | Icici Bank Limited | ₹4.75 Cr | Satisfied |
09 Dec 1997 | State Bank Of India | ₹1.91 Cr | Satisfied |
31 Mar 1997 | Maharashtra State Financial Corporation | ₹1.21 Cr | Satisfied |
How Many Employees Work at Naprod Life Sciences?
Naprod Life Sciences has a workforce of 504 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Naprod Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Naprod Life Sciences's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.